Passage Bio Inc. (PASG) Fundamentals

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
SHARE INFORMATION
Market Cap$ 115,462,058
Shares Outstanding54,463,235
Float42,785,155
Percent Float78.56%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -3.48
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions266
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months2,200,126
Institutional Holdings Percent74.3%
Institutional Sold Previous 3 Months8,950,695
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months1,709,800
Insider Holdings Percent3.2
Insider Sold Previous 3 Months-
Insider Shares Owned1,759,757
TRADING INFO
52 Week High$ 12.42
52 Week Low$ 1.57
52 Week High Change$ -82.00
21 Day Moving Average$ 2.0905
21 Day Extended Moving Average$ 2.1073
50 Day Moving Average$ 2.2572
50 Day Extended Moving Average$ 2.2161
200 Day Moving Average$ 4.0888
200 Day Extended Moving Average$ 4.589
10 Day Average Volume451,418
20 Day Average Volume311,592
30 Day Average Volume282,523
50 Day Average Volume456,509
Alpha-0.072252
Beta1.0527
Standard Deviation0.214541
R20.083028
7 Day Price Change$ -0.10
7 Day Percent Change-4.5%
21 Day Price Change$ -0.09
21 Day Percent Change-4.07%
30 Day Price Change$ -0.21
30 Day Percent Change-9.01%
Month to Date Price Change$ 0.25
Month to Date Percent Change13.37%
Quarter to Date Price Change$ -0.24
Quarter to Date Percent Change-10.17%
180 Day Price Change$ -1.98
180 Day Percent Change-48.29%
200 Day Price Change$ -2.83
200 Day Percent Change-57.17%
Year to Date Price Change$ -4.23
Year to Date Percent Change-66.61%

Passage Bio Inc. (PASG) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio9.20
Leverage Ratio1.10
Quick Ratio8.80
Long Term Debt To Capital0.09
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ -101,222,633
Price to Sales0.00
Price to Free Cash-0.70
PE High Last 5 Years0.00
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-48.83
Return on Equity-55.49
Return on Capital-51.30

Passage Bio Inc. (PASG) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEOBruce Goldsmith
Emplyoees133
Last AuditUQ
CIK0001787297
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2005 Market Street
39th Floor, One Commerce Square
Philadelphia, PA 19103
Websitehttps://www.passagebio.com
Facsimile-
Telephone+1 267 866-0311
Email-


Your Recent History
NASDAQ
PASG
Passage Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.